Lanean...
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
In recent years, as our understanding of tumor immunology is continuously improved, immunotherapy has come to the center stage of cancer therapy and is deemed as the most promising approach for cancer control. Although immunotherapy, particularly immune checkpoint blockade (ICB), has achieved a mile...
Gorde:
| Argitaratua izan da: | Front Cell Dev Biol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7746821/ https://ncbi.nlm.nih.gov/pubmed/33344447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.580140 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|